JB Chemicals is the preferred pick in the Pharma sector: Nirmal Bang

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Dec 19, 2022.

  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Mar 19, 2015
    Likes Received:
    JB Chem is the preferred pick in Pharma sector due to its aggressive growth focus in the domestic market, strong financials &healthy FCF. Its units are low risk with no USFDA inspections since 2019. No product recall or serious complaints in last 14 years

    JB Chem is a steady performer going from strength to strength. The stock has given 600% gain in 5 years & 28% YoY. It is almost debt-free, has RoE of 18%. TTM P/E of 41x is lower than Sun Pharma (58) but higher than Cipla (35), Divis (30) & Dr Reddy (24). Dividend yield is 0.8%

    Download research report